Chart Review of Outcome of Treatment for S. Aureus Bacteremia

This study has been completed.
Sponsor:
Collaborator:
Baylor College of Medicine
Information provided by:
VA Medical Center, Houston
ClinicalTrials.gov Identifier:
NCT00304902
First received: March 16, 2006
Last updated: September 9, 2010
Last verified: September 2010
  Purpose

The purpose of this study is to review medical records at MEDVAMC in order to relate the outcome of bacteremic MRSA infection to the antibiotics selected for treatment.


Condition
Staphylococcus Aureus

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: Retrospective Chart Review of the Outcome of Treatment for Staphylococcus Aureus Bacteremia

Resource links provided by NLM:


Further study details as provided by VA Medical Center, Houston:

Enrollment: 120
Study Start Date: February 2006
Study Completion Date: August 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 64 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All patients with Staphylococcus aureus in a blood culture.

Criteria

Inclusion Criteria:

  • Patients with Staphylococcus aureus in a blood culture between January 1, 2004 and December 31, 2005.

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00304902

Locations
United States, Texas
Michael E. DeBakey Veterans Affairs Medical Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
VA Medical Center, Houston
Baylor College of Medicine
Investigators
Principal Investigator: Daniel M Musher, M.D. Baylor College of Medicine, Houston VA Medical Center
  More Information

No publications provided

Responsible Party: Nancy Logan, MA, VAMC
ClinicalTrials.gov Identifier: NCT00304902     History of Changes
Other Study ID Numbers: H-18867
Study First Received: March 16, 2006
Last Updated: September 9, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by VA Medical Center, Houston:
MRSA
Methicillin Resistant Staphylococcus aureus
Staphylococcus aureus Bacteremia

Additional relevant MeSH terms:
Bacteremia
Staphylococcal Infections
Bacterial Infections
Sepsis
Infection
Systemic Inflammatory Response Syndrome
Inflammation
Pathologic Processes
Gram-Positive Bacterial Infections

ClinicalTrials.gov processed this record on July 23, 2014